Hypoglycemic drugs are medications prescribed to treat low blood sugar levels and reduce sugar levels in diabetic patients. Short-acting sulfonylureas and biguanides are commonly prescribed oral medications to control blood glucose levels and minimize health risks associated with fluctuating sugar levels.
The global Hypoglycemic Drugs Market is estimated to be valued at US$ 720.72 Mn in 2023...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian